Analyzing gut bacteria in pancreatic diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze the digestive flora structure in patients with pancreatic cancer compared to those with other pancreatic diseases and healthy individuals. Participants will provide samples such as stool, blood, and digestive secretions, with additional tissue samples collected from those undergoing surgery. The goal is to identify differences in microbial communities among these groups and to uncover potential biomarkers and pathogenic mechanisms related to pancreatic diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 3 years old, ≤ 85 years old;
* After MDT discussion, routine surgery or ERCP can be performed, and the postoperative pathology is clear as pancreatic cancer and other pancreatic diseases;
* There is no serious damage to heart, liver and kidney function;

Exclusion Criteria:

* Women who are breast-feeding during pregnancy and after pregnancy;
* Patients with evidence of sensory or motor neuropathy;
* Those who have a clear cardiovascular disease, severe associated disease or active infection, including known HIV infection;
* Those who have a history of other cancers;
* Those who are allergic to drugs or their excipients

Where it's running

• Ruijin Hospital
  Shanghai, Shanghai, China Recruiting

Study contacts

• Principal investigator: Wei WANG, Dr. — Ruijin Hospital
• Study coordinator: Wei WANG, Dr.
• Email: wangwei_0306@163.com
• Phone: +86-13761648121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two methods for examining gastrointestinal lesions

  This study is testing whether a new imaging system for examining gastrointestinal lesions works better than the standard method for people undergoing endoscopic ultrasound.

  Recruiting Orlando Health, Inc. · Orlando, Florida · NCT06340620

• Collecting medical information and tissue samples from patients with pancreatic disorders

  This study is collecting medical information and samples from people with pancreatic cancer or other pancreatic disorders to help find better ways to detect and treat these diseases.

  Recruiting at 3 sites Mayo Clinic · Phoenix, Arizona and 2 other locations · NCT00830557

• Integrated genomic and clinical database for cancer biomarker discovery

  Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.

  Recruiting Samsung Medical Center · Seoul, Gang-Nam · NCT07911267

• Using contrast-enhanced ultrasound to check for local pancreatic cancer recurrence after surgery

  This pilot test uses contrast-enhanced ultrasound to see if it can help detect return of pancreatic cancer after surgery in patients being watched with CT scans.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07910383

• Combination of ivermectin with standard skin-protective care for daraxonrasib-related skin toxicity in pancreatic cancer

  This study tests whether adding ivermectin to standard preventive skin care helps people with pancreatic cancer who develop skin side effects from daraxonrasib.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07895498

• Becotatug Vedotin Plus Anti-PD-1 and S-1 in EGFR-Positive Advanced Pancreatic Cancer

  This study tests a three-drug regimen (becotatug vedotin, an anti-PD-1 therapy, and S-1) in adults with EGFR-positive advanced pancreatic cancer who have not responded to at least one prior therapy.

  Recruiting Ningbo Medical Center Lihuili Hospital · Ningbo, Zhejiang · NCT07892573

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.